Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells
Open Access
- 16 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 13 (4), e12409
- https://doi.org/10.15252/emmm.202012409
Abstract
Toll‐like receptor (TLR) stimulation induces innate immune responses involved in many inflammatory disorders including psoriasis. Although activation of the AP‐1 transcription factor complex is common in TLR signaling, the specific involvement and induced targets remain poorly understood. Here, we investigated the role of c‐Jun/AP‐1 protein in skin inflammation following TLR7 activation using human psoriatic skin, dendritic cells (DC), and genetically engineered mouse models. We show that c‐Jun regulates CCL2 production in DCs leading to impaired recruitment of plasmacytoid DCs to inflamed skin after treatment with the TLR7/8 agonist Imiquimod. Furthermore, deletion of c‐Jun in DCs or chemical blockade of JNK/c‐Jun signaling ameliorates psoriasis‐like skin inflammation by reducing IL‐23 production in DCs. Importantly, the control of IL‐23 and CCL2 by c‐Jun is most pronounced in murine type‐2 DCs. CCL2 and IL‐23 expression co‐localize with c‐Jun in type‐2/inflammatory DCs in human psoriatic skin and JNK‐AP‐1 inhibition reduces the expression of these targets in TLR7/8‐stimulated human DCs. Therefore, c‐Jun/AP‐1 is a central driver of TLR7‐induced immune responses by DCs and JNK/c‐Jun a potential therapeutic target in psoriasis.Keywords
Funding Information
- Austrian Science Fund (W1212, P27129‐B20, I 4300‐B, P2572, W1241)
- H2020 Excellent Science (ERC‐2015‐AdG TNT‐Tumors 694883)
- Vienna Science and Technology Fund (LS16‐025)
- H2020 Excellent Science (766214)
- H2020 Excellent Science (ITN‐2019‐859860 ‐ CANCERPREV)
This publication has 60 references indexed in Scilit:
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variationNucleic Acids Research, 2012
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Psoriasis: what we have learned from mouse modelsNature Reviews Rheumatology, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- AP-1 Activated by Toll-like Receptors Regulates Expression of IL-23 p19Online Journal of Public Health Informatics, 2009
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8The Journal of Experimental Medicine, 2009
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic CellsJournal of Investigative Dermatology, 2009
- TLR7 and CD40 cooperate in IL‐6 production via enhanced JNK and AP‐1 activationEuropean Journal of Immunology, 2008
- Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleenThe Journal of Experimental Medicine, 2007
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004